2573. Academic Partnership with Public Health: Infectious Diseases at the Population-Level
Session: Named Lecture: Joseph E. Smadel Lecture
Saturday, October 6, 2018: 3:30 PM
Room: N Hall D
Monica M. Farley, MD, FIDSA, Department of Medicine, Emory University School of Medicine and Atlanta VA Medical Center, Atlanta, GA

Dr. Monica Farley is the Jonas A. Shulman Professor of Medicine and the Director of the Division of Infectious Diseases at Emory University School of Medicine and a Staff Physician at the Atlanta VA Medical Center. She is Past-President of the American Federation for Medical Research and a longstanding council member and Past-President of the Southern Society for Clinical Investigation. She has served on the Women’s Committee, the Program Planning Committee and the Public Health Committee in IDSA. Dr. Farley leads a large infectious diseases division at Emory made up of nearly 70 faculty members with a large research portfolio. She serves as the academic Principal Investigator for the Georgia Emerging Infections Program (EIP), a CDC-funded surveillance network conducting applied epidemiologic and laboratory research focused on invasive bacterial pathogens, influenza, foodborne diseases, and healthcare-associated infections. She is a past member of the US Food and Drug Administration (FDA) Advisory Committee on Vaccines and Related Biological Products and she currently serves on the Pneumococcal Vaccine Working Group for CDC’s Advisory Committee on Immunization Practices (ACIP). The collaborative EIP research program has been highly productive, providing population-based assessment of the epidemiology and risk factors for a number of important bacterial infections, including adult and pediatric Group B Streptococcal infections, pneumococcal disease and community-associated MRSA, and performing post-licensure vaccine effectiveness studies.


Disclosures:

M. M. Farley, None

See more of: Joseph E. Smadel Lecture
See more of: Named Lecture

Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 3rd with the exception of research findings presented at the IDWeek press conferences.